Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Bioharvest Sciences Inc (CSE: BHSC )

8.550 -0.090 (-1.04%)
Official Closing Price Updated: 3:46 PM EST, Nov 25, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 2,750
Open 8.690
Bid (Size) 8.300 (100)
Ask (Size) 8.700 (1,000)
Prev. Close 8.640
Today's Range 8.550 - 8.690
52wk Range 0.1650 - 9.200
Shares Outstanding N/A
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
BioHarvest Sciences Reports Third Quarter 2024 Financial Results
Vancouver, British Columbia and Rehovot, Israel--(Newsfile Corp. - November 25, 2024) - BioHarvest Sciences Inc. (NASDAQ: BHST) (CSE: BHSC) (FSE:... 
Via Newsfile
BioHarvest Launches VINIA SuperFood Functional Tea Line
Vancouver, British Columbia and Rehovot, Israel--(Newsfile Corp. - November 25, 2024) - BioHarvest Sciences Inc. (NASDAQ: BHST) (CSE: BHSC) (FSE: 8MV0)... 
Via Newsfile

Performance

YTD
+3971.43%
+3971.43%
1 Month
+26.67%
+26.67%
3 Month
+16.17%
+16.17%
6 Month
+3320.00%
+3320.00%
1 Year
+4785.71%
+4785.71%

More News

Read More
BioHarvest Sciences to Participate in Noble Capital Markets Emerging Growth Conference on December 3, 2024
Via Newsfile
BioHarvest Sciences to Host Third Quarter 2024 Earnings Call on November 25 at 4:30 P.M. Eastern Time
Via Newsfile
Topics Earnings
Exposures Financial
BioHarvest Sciences Begins Trading on the Nasdaq Global Market
Via Newsfile
BioHarvest Sciences Announces Uplisting to the Nasdaq Global Market
Via Newsfile
BioHarvest Sciences Announces Record Preliminary Third Quarter 2024 Financial Results
Via Newsfile
BioHarvest Sciences to Participate in LD Micro Main Event XVII Conference on October 30, 2024
Via Newsfile
BioHarvest Sciences Reports Director's Ongoing Key Role Following Resignation from Board
Via Newsfile
iAccess Alpha's Buyside Best Ideas Virtual Fall Conference September 24-25, 2024
Via ACCESSWIRE
BioHarvest Sciences to Participate in iAccess Alpha Buyside Best Ideas Conference on September 24-25, 2024
Via Newsfile
BioHarvest Sciences to Present at H.C. Wainwright 26th Annual Global Investment Conference
Via Newsfile
BioHarvest Sciences Reports Record Second Quarter 2024 Financial Results
Via Newsfile
BioHarvest Sciences Surpasses USD $1.0 Million in Cumulative Direct Sales of Coffee with VINIA Inside
Via Newsfile
BioHarvest Sciences to Host Second Quarter 2024 Corporate Update Call on August 29, 2024, at 2:30 p.m. Eastern Time
Via Newsfile
BioHarvest Sciences Announces Closing of USD $4,329,982 in First Tranche of Private Placement and Conversion of Debt Notes
Via Newsfile
BioHarvest Sciences to Present at Noble Capital Markets Virtual Equity Conference on June 27, 2024
Via Newsfile
BioHarvest Sciences Announces a Private Placement of up to USD $5 Million and Conversion of Debt Notes
Via Newsfile
BioHarvest Sciences to Present at Sidoti Small-Cap Virtual Investor Conference on June 13, 2024
Via Newsfile
BioHarvest Sciences Announces Record $2 Million Monthly Sales
Via Newsfile
BioHarvest Sciences Reports First Quarter 2024 Financial Results
Via Newsfile
BioHarvest Sciences to Host Corporate Update Call May 2 at 2:30 P.M. Eastern Time
Via Newsfile
BioHarvest Sciences Reports Fourth Quarter and Full Year 2023 Financial Results
Via Newsfile
BioHarvest Sciences Announces New Campus for Botanical Synthesis CDMO and Expansion of Manufacturing Capacity
Via Newsfile
BioHarvest Sciences Appoints Anna Tenstam as VP of Business Development, Cosmeceuticals and Injectables
Via Newsfile
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.